European eating disorders review : the journal of the Eating Disorders Association · 2026
Eating Disorders and Parkinson's Disease-1: Comorbidities, Neurobiology, and Family History.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Krueger Angeline, Bergen Andrew W, Litvan Irene, Filoteo Vincent, Makowski Carolina, Murray Susan, McGlone Karlee, Garvin Michael, Drouin Andi, Kauffman Alyssa, Steele Caroline, Hower Heather, Kaye Walter H
Аннотация
OBJECTIVE: Eating disorders (ED), particularly anorexia nervosa (AN), share neurobiological characteristics with Parkinson's Disease (PD) (e.g., premorbid anxiety, dopaminergic dysfunction, harm avoidance, weight loss), suggesting common vulnerability. The present study built upon these observations, an AN patient's reported family history of Parkinson's Disease (RFHoPD), and AN:PD genetic correlation estimates, by ascertaining RFHoPD in families of individuals with PD.
METHOD: We ascertained RFHoPD among ED patients and community participants, and estimated relative risks (RRs) for AN, Bulimia Nervosa (BN), and Binge Eating Disorder (BED).
RESULTS: In the total sample (N = 1135), we observed increased RFHoPD among patients and community participants meeting criteria for ED diagnoses (n = 727) versus community participants without an ED diagnosis (n = 408). For AN, RFHoPD prevalence was 6.6%, versus 3.4% (χ2 = 4.638, p = 0.031, RR = 1.935, 95% Confidence Interval [CI] = 1.012-3.768). For BN, RFHoPD prevalence was 7.4%, versus 3.4% (χ2 = 4.941, p = 0.026, RR = 2.169, 95% CI = 1.023-4.620). For BED, RFHoPD prevalence was 13.3%, versus 3.4% (χ2 = 6.953, p = 0.008, RR = 3.886, 95% CI = 1.108-11.524).
CONCLUSIONS: ED are associated with elevated RFHoPD. Analyses leveraging disorder-specific research may improve understanding of shared risk factors.
METHOD: We ascertained RFHoPD among ED patients and community participants, and estimated relative risks (RRs) for AN, Bulimia Nervosa (BN), and Binge Eating Disorder (BED).
RESULTS: In the total sample (N = 1135), we observed increased RFHoPD among patients and community participants meeting criteria for ED diagnoses (n = 727) versus community participants without an ED diagnosis (n = 408). For AN, RFHoPD prevalence was 6.6%, versus 3.4% (χ2 = 4.638, p = 0.031, RR = 1.935, 95% Confidence Interval [CI] = 1.012-3.768). For BN, RFHoPD prevalence was 7.4%, versus 3.4% (χ2 = 4.941, p = 0.026, RR = 2.169, 95% CI = 1.023-4.620). For BED, RFHoPD prevalence was 13.3%, versus 3.4% (χ2 = 6.953, p = 0.008, RR = 3.886, 95% CI = 1.108-11.524).
CONCLUSIONS: ED are associated with elevated RFHoPD. Analyses leveraging disorder-specific research may improve understanding of shared risk factors.